CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2022	$ 72,433	$ 3	$ 298,934	$ (226,536)	$ 32
Beginning Balance, Shares at Dec. 31, 2022		34,257,916
Net loss	(11,210)			(11,210)
Issuance of common stock under at-the-market offering, net of issuance costs	13,628	$ 1	13,627
Issuance of common stock under at-the-market offering, net of issuance costs, Shares		1,511,157
Stock-based compensation	980		980
Unrealized gain (loss) on short term investments	(24)				(24)
Ending Balance at Mar. 31, 2023	75,807	$ 4	313,541	(237,746)	8
Ending Balance, Shares at Mar. 31, 2023		35,769,073
Beginning Balance at Dec. 31, 2022	72,433	$ 3	298,934	(226,536)	32
Beginning Balance, Shares at Dec. 31, 2022		34,257,916
Net loss	(25,364)
Unrealized gain (loss) on short term investments	(38)
Ending Balance at Jun. 30, 2023	63,427	$ 4	315,329	(251,900)	(6)
Ending Balance, Shares at Jun. 30, 2023		35,849,482
Beginning Balance at Mar. 31, 2023	75,807	$ 4	313,541	(237,746)	8
Beginning Balance, Shares at Mar. 31, 2023		35,769,073
Net loss	(14,154)			(14,154)
Issuance of common stock upon exercise of stock options	101		101
Issuance of common stock upon exercise of stock options, Shares		18,000
Issuance of common stock under at-the-market offering, net of issuance costs	332		332
Issuance of common stock under at-the-market offering, net of issuance costs, Shares		33,333
Stock-based compensation	1,179		1,179
Unrealized gain (loss) on short term investments	(14)				(14)
Issuance of common stock through employee stock purchase plan	176		176
Issuance of common stock through employee stock purchase plan, Shares		29,076
Ending Balance at Jun. 30, 2023	63,427	$ 4	315,329	(251,900)	(6)
Ending Balance, Shares at Jun. 30, 2023		35,849,482
Beginning Balance at Dec. 31, 2023	37,218	$ 4	318,561	(281,346)	(1)
Beginning Balance, Shares at Dec. 31, 2023		35,968,510
Net loss	(14,108)			(14,108)
Issuance of common stock upon exercise of stock options	181		181
Issuance of common stock upon exercise of stock options, Shares		32,754
Vesting of restricted stock	(166)		(166)
Vesting of restricted stock, Shares		53,145
Stock-based compensation	1,440		1,440
Unrealized gain (loss) on short term investments	1				1
Ending Balance at Mar. 31, 2024	24,566	$ 4	320,016	(295,454)
Ending Balance, Shares at Mar. 31, 2024		36,054,409
Beginning Balance at Dec. 31, 2023	37,218	$ 4	318,561	(281,346)	$ (1)
Beginning Balance, Shares at Dec. 31, 2023		35,968,510
Net loss	$ (31,198)
Issuance of common stock upon exercise of stock options, Shares	8,411
Unrealized gain (loss) on short term investments	$ 1
Ending Balance at Jun. 30, 2024	9,250	$ 4	321,790	(312,544)
Ending Balance, Shares at Jun. 30, 2024		36,139,802
Beginning Balance at Mar. 31, 2024	24,566	$ 4	320,016	(295,454)
Beginning Balance, Shares at Mar. 31, 2024		36,054,409
Net loss	(17,090)			(17,090)
Stock-based compensation	1,491		1,491
Issuance of common stock through employee stock purchase plan	283		283
Issuance of common stock through employee stock purchase plan, Shares		85,393
Ending Balance at Jun. 30, 2024	$ 9,250	$ 4	$ 321,790	$ (312,544)
Ending Balance, Shares at Jun. 30, 2024		36,139,802